임상시험 환자 모집 서비스 시장 규모, 점유율, 성장 분석 : 서비스 유형별, 시험 유형별, 치료 분야별, 모집 방법별, 시험 단계별, 최종사용자별, 지역별 - 산업 예측(2026-2033년)

Global Clinical Trial Patient Recruitment Services Market size was valued at USD 5.8 Billion in 2024 and is poised to grow from USD 6.23 Billion in 2025 to USD 11.03 Billion by 2033, growing at a CAGR of 7.4% during the forecast period (2026-2033).

The global market for clinical trial patient recruitment services is characterized by a diverse array of suppliers, including agencies, technology platforms, and clinical research organizations, all focused on effectively enrolling participants in therapeutic and device studies. Traditional recruitment methods, such as site-based referrals and physician networks, are evolving due to an increase in global clinical trials. Companies are now leveraging digital advertising, patient registries, and advocacy groups for enhanced outreach. The integration of electronic health records and genomic databases, along with targeted digital strategies, is accelerating patient recruitment, minimizing protocol modifications and site visits. Additionally, innovative decentralized methods, including e-consent and remote monitoring, are expanding access to participants in underserved regions, presenting significant market opportunities for providers skilled in regulatory compliance and analytics.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Clinical Trial Patient Recruitment Services market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Clinical Trial Patient Recruitment Services Market Segments Analysis

Global clinical trial patient recruitment services market is segmented by service type, study type, therapeutic area, recruitment method, phase, end user and region. Based on service type, the market is segmented into Patient Recruitment, Patient Retention, Site Support Services, Feasibility & Enrollment Planning and Others. Based on study type, the market is segmented into Interventional Studies and Observational Studies. Based on therapeutic area, the market is segmented into Oncology, Cardiovascular Disorders, Neurological Disorders, Infectious Diseases, Rare Diseases and Others. Based on recruitment method, the market is segmented into Digital Recruitment, Physician Referral Recruitment, Patient Registry Recruitment, Community-Based Recruitment and Others. Based on phase, the market is segmented into Phase I, Phase II, Phase III and Phase IV. Based on end user, the market is segmented into Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations (CROs) and Academic & Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Clinical Trial Patient Recruitment Services Market

The Global Clinical Trial Patient Recruitment Services market is driven by the advances in digital platforms that enhance the identification, engagement, and retention of potential trial participants. These integrated tools, including patient portals, social media outreach, and telehealth interfaces, streamline pre-screening, automate communication, and facilitate remote consent processes, effectively lowering participation barriers and extending reach beyond conventional clinical sites. Enhanced user experiences and centralized data management foster ongoing communication and participant adherence. By harnessing these innovations, service providers can craft tailored recruitment campaigns, sustain participant involvement throughout the study timeline, and effectively connect underrepresented populations with relevant clinical trials.

Restraints in the Global Clinical Trial Patient Recruitment Services Market

The Global Clinical Trial Patient Recruitment Services market faces considerable challenges due to the inconsistencies in regulatory frameworks, ethical guidelines, and data protection standards across different regions. These variations introduce substantial complexities for recruitment service providers aiming to function on an international scale. Providers must navigate a myriad of local consent requirements, approval processes, and privacy regulations, necessitating tailored recruitment strategies and legal guidance, which complicates operations. This fragmentation impedes the development of standardized recruitment solutions and hinders the swift scalability of services, ultimately limiting the effectiveness of centralized recruitment models and slowing the expansion of global service offerings.

Market Trends of the Global Clinical Trial Patient Recruitment Services Market

The Global Clinical Trial Patient Recruitment Services market is witnessing a notable shift towards AI-assisted candidate matching, revolutionizing how patients are identified and engaged for clinical trials. By leveraging advanced algorithms and predictive profiling, companies can seamlessly integrate various data sources to automate eligibility screening and enhance outreach. This approach not only streamlines the recruitment process but also prioritizes candidates with a higher likelihood of participation, thereby increasing trial success rates. As reliance on these innovative tools grows, service providers are likely to emphasize interoperability and model transparency, fostering trust and supporting scalable, patient-centric recruitment strategies across diverse therapeutic areas worldwide.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape
• Value Chain Analysis
• Case Studies
• Technology Assessment
• Customer & Buying Criteria Analysis
• Pipeline Analysis
• Disease Epidemiology

Global Clinical Trial Patient Recruitment Services Market Size by Service Type & CAGR (2026-2033)

• Market Overview
• Patient Recruitment
• Patient Retention
• Site Support Services
• Feasibility & Enrollment Planning
• Others

Global Clinical Trial Patient Recruitment Services Market Size by Study Type & CAGR (2026-2033)

• Market Overview
• Interventional Studies
• Observational Studies

Global Clinical Trial Patient Recruitment Services Market Size by Therapeutic Area & CAGR (2026-2033)

• Market Overview
• Oncology
• Cardiovascular Disorders
• Neurological Disorders
• Infectious Diseases
• Rare Diseases
• Others

Global Clinical Trial Patient Recruitment Services Market Size by Recruitment Method & CAGR (2026-2033)

• Market Overview
• Digital Recruitment
• Physician Referral Recruitment
• Patient Registry Recruitment
• Community-Based Recruitment
• Others

Global Clinical Trial Patient Recruitment Services Market Size by Phase & CAGR (2026-2033)

• Market Overview
• Phase I
• Phase II
• Phase III
• Phase IV

Global Clinical Trial Patient Recruitment Services Market Size by End User & CAGR (2026-2033)

• Market Overview
• Pharmaceutical Companies
• Biotechnology Companies
• Contract Research Organizations (CROs)
• Academic & Research Institutes

Global Clinical Trial Patient Recruitment Services Market Size & CAGR (2026-2033)

• North America (Service Type, Study Type, Therapeutic Area, Recruitment Method, Phase, End User)
  • US
  • Canada
• Europe (Service Type, Study Type, Therapeutic Area, Recruitment Method, Phase, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Service Type, Study Type, Therapeutic Area, Recruitment Method, Phase, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Service Type, Study Type, Therapeutic Area, Recruitment Method, Phase, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Service Type, Study Type, Therapeutic Area, Recruitment Method, Phase, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• IQVIA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fortrea
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Parexel
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ICON plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Syneos Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medpace
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Worldwide Clinical Trials
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Precision for Medicine
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Accelerated Enrollment Solutions
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AutoCruitment
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Clariness
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BBK Worldwide
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Antidote Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trialbee
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SubjectWell
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CVS Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elligo Health Research
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PharmaSeek
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• M3 Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations